D. Yu

Comparison of clinical outcomes and risk factors for COVID-19 infection in cancer patients without anticancer treatment and noncancer patients

Xuhua Ge, X. Niu, Qiangqiang Fu, 2022, Frontiers in Public Health.

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer

Jinyun Dong, Xuefei Yu, Jiangjiang Qin, 2022, Frontiers in Pharmacology.

Inhibition of STAT3 Signaling Pathway by Terphenyllin Suppresses Growth and Metastasis of Gastric Cancer

Qinglin Li, Weiyi Wang, X. Guan, 2022, Frontiers in Pharmacology.

Dual inhibition of MYC and SLC39A10 by a novel natural product STAT3 inhibitor derived from Chaetomium globosum suppresses tumor growth and metastasis in gastric cancer.

B. Zhao, Weiyi Wang, Jinyun Dong, 2023, Pharmacological research.

The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.

Lin Xu, Q. Ji, Jia Huang, 2014, Lung cancer.

Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets

Shuqiong Fan, Lili Tang, Jiafu Ji, 2014, Genes, chromosomes & cancer.

S3I-201 derivative incorporating naphthoquinone unit as effective STAT3 inhibitors: Design, synthesis and anti-gastric cancer evaluation.

Jinyun Dong, Chu Chu, Jiangjiang Qin, 2022, Bioorganic & medicinal chemistry.

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma

Yingyong Hou, G. Zhu, Z. Qian, 2015, BMC Cancer.